Term
|
Definition
- minimum alveolar concentration that will inhibit movement in response to skin incision in 50% of pts
- measure of potency (lower MAC = more potent) |
|
|
Term
|
Definition
- inspired dose that will abolish fighting reflex in 50% of mice
- effective dose |
|
|
Term
|
Definition
- ratio of amt of inhaled anesthetic in blood to amt in tissue
- measure of solubility of gas in blood
- lower number (low in blood, high in tissue) = lower solubility in blood = faster acting
- must be soluble enough to cross BBB, but insoluble enough to leave blood to go to brain tissue
|
|
|
Term
How is dosage of N20 controlled? |
|
Definition
- by watching level of sedation of pt |
|
|
Term
How is halothane eliminated? |
|
Definition
- 60-80% exhaled unchanged
- some by CYP450 in liver |
|
|
Term
Metabolites of Inhaled Anesthetics |
|
Definition
Halothane - trifluoroacetic acid
Sevoflurane - hexafluoroisopropanol
|
|
|
Term
What is the main toxicity risk for halothane? |
|
Definition
|
|
Term
CV side effects of halothane |
|
Definition
- bradycardia
- atrioventricular arrhythmia
- decreased BP and HR (due to attenuation of depolarization)
- dilation of vascular beds of skin and brain (systemic resistance unchanged) |
|
|
Term
Respiratory side effects of halothane |
|
Definition
- decreased in alveolar ventilation
- CO2 accumulation
- bronchodilation |
|
|
Term
CNS side effects of halothane |
|
Definition
- increase in intercranial pressure
- decrease in cerebral blood flow and metabolism
|
|
|
Term
Muscular side effects of Halothane |
|
Definition
- relaxation
- trigger for malignant hyperthermia |
|
|
Term
|
Definition
- low partition coefficient (so rapid onset)
- metabolized slowly (only desflurane is slower) - 0.2% |
|
|
Term
|
Definition
- low partition coefficient (rapid onset, offset)
- 3% metabolized by CYP450 |
|
|
Term
CV side effects of Sevoflurane |
|
Definition
|
|
Term
Respiratory effects of sevoflurane |
|
Definition
- reduction in tidal volume
- increase in respiratory rate
- bronchodilation
- increase in CO2 (measured w/ capnographer) |
|
|
Term
What 2 emergency meds should you keep in your office? |
|
Definition
valium - seizures
morphine - myocardial infarction |
|
|
Term
CNS effects of sevoflurane |
|
Definition
(Same as Halothane)
- increase in intercranial pressure
- decrease in cerebral blood flow and metabolism |
|
|
Term
What is the only gas that is not a trigger for malignant hyperthermia? |
|
Definition
|
|
Term
Muscular effects of sevoflurane |
|
Definition
(Same as Halothane)
- relaxation
- trigger for malignant hyperthermia |
|
|
Term
In the production of N2O, what is the danger of heating too high? |
|
Definition
- creation of large amt of NO (which acts like CO) |
|
|
Term
What is the only non-organic compound w/ CNS depressant properties? |
|
Definition
|
|
Term
Blood:Gas Coefficients of Inhaled Anesthetics |
|
Definition
Desflurane = .42
Nitrous = .47
Isoflurane = 1.46
Halothane = 2.54
|
|
|
Term
MACs of Inhaled Anesthetics |
|
Definition
Nitrous = 104
Desflurane = 6
Isoflurane = 1.15
Halothane = .77 |
|
|
Term
|
Definition
- low solubility in blood (.47), so can leave and enter spaces normally filled with air (middle ear or lung), causing increased pressure
- BUT, 35x more soluble than N2 and 100x more soluble than O2 |
|
|
Term
What is the max concentration of N2O that delivery machines allow? |
|
Definition
|
|
Term
Concentration effect of N2O |
|
Definition
- at high rates of flow, N2O fills up spaces faster than N2 or O2 can leave, causing increase in arterial tension |
|
|
Term
|
Definition
- rapid release of N2O will cause vacuum effect in alveoli, causing 2nd gas to rush in
- increases onset time of other inhaled anesthetics |
|
|
Term
|
Definition
- vast majority exhaled w/ in 3-5 minutes (no reservoir)
- 1% eliminated thru skin and lungs
- small amt of degradation by anaerobic bacteria in gut |
|
|
Term
Diffusion Hypoxia (Fick Principle) |
|
Definition
- N2O leaves lungs very rapidly upon termination, flushing other gases (O2) out with it
- pt may become hypoxic (accompanied by nausea) and pass out
- counteract w/ administration of 100% O2 for 3-5 min upon termination |
|
|
Term
|
Definition
- vasodilation
- mild depression of contraction |
|
|
Term
Respiratory effects of N2O |
|
Definition
- non-irritating (OK for asthmatics)
- no increased risk of bronchospasm
|
|
|
Term
|
Definition
- none
- BUT, may see bloating |
|
|
Term
Hematopoietic effects of N2O |
|
Definition
- inhibits methionine synthetase (vitamin B12 metabolism)
- long term exposure = pernicious anemia
- chronic short term exposure = B12 deficiency w/ neuropathy |
|
|
Term
|
Definition
- none w/ scavenging
- w/o scavenging, 2.6 risk of spontaneous abortion |
|
|
Term
What is the recommended concentration of N2O (ppm) in the US? |
|
Definition
|
|
Term
|
Definition
systemic - slight vasoconstriction
pulmonary capillaries - vasodilation |
|
|
Term
How do you determine proper flow rate of N2O? |
|
Definition
- watch reservoir bag (should shrink slightly on inhalation and expand slightly on exhalation) |
|
|
Term
Initiation of N2O administration |
|
Definition
- start w/ 100% O2 at 6L / minute
- then introduce N2O at 20% for 2-5 min
- increase N2O in 10% increments as needed |
|
|
Term
|
Definition
- dentist's role in sedation
- calmness, gentleness, careful explanation, etc. |
|
|
Term
What is the color coding for N2O and O2? |
|
Definition
N2O = light blue
O2 = green (or white, internationally) |
|
|
Term
What are the contraindications for N2O? |
|
Definition
|
|
Term
|
Definition
- includes 1 agent of oral sedation that does not exceed max recommended dose
- no loss of protective reflexes |
|
|
Term
|
Definition
- multiple agents exceeding MRD
- and/or IV
- minimal effect on protective reflexes
|
|
|
Term
|
Definition
- partial loss of protective reflexes
- airway may be affected |
|
|
Term
|
Definition
- loss of all protective reflexes
- intubation |
|
|
Term
|
Definition
- ease of administration
- low cost
- decreased incidence/severity of adverse reactions
- reduced armamentarium |
|
|
Term
Disadvantages of Oral Meds |
|
Definition
- prolonged latent period (b/w administration and effect: 30 min)
- incomplete/erratic absorption of drug
- inability to titrate
- prolonged duration |
|
|
Term
What criteria determine dosage and choice of oral sedatives? |
|
Definition
- desired depth of sedation
- procedure length
- half-life
- pt ASA status |
|
|
Term
What is the dental dose of EtOH? |
|
Definition
- 2 oz. 20 min. prior to appt. |
|
|
Term
What is the main side effect of barbiturates? |
|
Definition
- respiratory depression(irreversible) |
|
|
Term
|
Definition
-1st effective sedative used in dentistry
- CNS depressant
- no analgesic properties
- hepatotoxicity
- only use when benzodiazepines ineffective |
|
|
Term
|
Definition
- form of EtOH
- CNS depressant
- gastric irritant (vomiting common)
- dental dose = 500-1000mg, 1 hr before appt.
- primarily used in pediatrics |
|
|
Term
|
Definition
- opioid
- mix of meperidine (narcotic) and promethazine (antihistamine)
- CNS depressant
- should only be used for pain management |
|
|
Term
|
Definition
- decreased hangover
- fewer side effects
- wide safety margin at MRD
- CNS (limbic) depression by inhibiting GABA reuptake
- rapidly absorbed
- 1/2 life of 1.5-70 hrs |
|
|
Term
CNS effects of benzodiazepines |
|
Definition
- reduces hostile/aggressive behavior
- muscle relaxant |
|
|
Term
CV effects of benzodiazepines |
|
Definition
|
|
Term
Respiratory effects of benzodiazepines |
|
Definition
- depression in compromised pts |
|
|
Term
Liver effects of benzodiazepines |
|
Definition
- metabolized in liver, but does not stimulate induction of CYP450 enzymes |
|
|
Term
How many 1/2 lives does a drug usually pass thru before it can be said to have been completely eliminated? |
|
Definition
|
|
Term
Adverse reactions to benzodiazepines |
|
Definition
- ataxia
- drowsiness
- fatigue |
|
|
Term
Paradoxical reaction to benzodiazepines |
|
Definition
- excitement, hallucinations, insomnia, rage
- whatever was keeping their emotions in check has been eliminated |
|
|
Term
|
Definition
- good antianxiety med
- no active metabolites (few side effects)
- rapid onset
|
|
|
Term
|
Definition
- short-term retrograde amnesia
|
|
|
Term
|
Definition
- IV or oral liquid
- sedation and profound amnesia
- interacts w/ many other drugs |
|
|
Term
|
Definition
alprazolam/xanax - 8-12 hrs
triazolam/halcion - 2-3 hrs
midazolam/versed - 2-4 hrs |
|
|
Term
|
Definition
alprazolam/xanax - .5-1mg at bedtime or 1 hr before appt
triazolam/halcion - .25-.5mg 1 h before appt (after 1/2 life expires, may supplement w/ 1/2 of initial dose)
midazolam/versed - IV = 5-10mg, Oral = 15-20mg |
|
|
Term
|
Definition
- reverses effect of benzodiazepine
- sublingual injection
- could cause seizures in epileptics |
|
|
Term
|
Definition
- sleeping pills
- approved for sedation
- rapid onset (30-60 min)
- short duration (4 hrs)
- inhibit GABA reuptake |
|
|
Term
Zolpidem/Ambien adverse effects |
|
Definition
short term - headache, myalgia, dizziness, nausea
long term - xerostomia
|
|
|
Term
|
Definition
zolpidem/ambien - 1.5 hr
zaleplon/sonata - 1-2 hrs |
|
|
Term
|
Definition
- used for their side effects
- antiemetic
- analgesic at high doses |
|
|
Term
|
Definition
- in pediatrics to produce light sleep (NOT unconsciousness, respiratory or CV depression) |
|
|
Term
Adverse effects of promethazine/phenergan |
|
Definition
- postural hypotension
- xerostomia
- blurry vision
- syncope
- reacts w/ other CNS depressants
- may lower seizure thresholds |
|
|
Term
|
Definition
- decongestant
- minimal/moderate sedation
|
|
|
Term
|
Definition
promethazine/phenergan - 20-50mg
hydroxyzine/atarax - 10-50mg |
|
|
Term
|
Definition
I - analgesia/sedation (dental use)
II - delirium/excitement (might be mistaken for insufficient dose)
III - surgical anesthesia (loss of protective reflex, spontaneous respiration)
IV - medullary paralysis / death |
|
|
Term
|
Definition
- gold standard of pt monitoring
- measures amt of oxygenated blood in circulation (via red and infrared light absorption by oxyHb and deoxyHb)
- do not use exclusively |
|
|
Term
Principles of Antibiotics |
|
Definition
- use broad spectrum (but don't want to wipe out everything)
- use bactericidal ove bacteriostatic (e.g., PCN over tetracyclene)
- use correct dosage for pt's weight
- use drugs with least side effects / lowest cost
- appropriate length of therapy, intervals b/w doses |
|
|
Term
|
Definition
- nausea, vomiting, diarrhea, allergic rxn (cross allergy w/ cephalosporins)
- 500mg qid
- 250 or 500mg capsules |
|
|
Term
|
Definition
- less bactericidal than PenVK
- side effects similar to PCN, but most common cause of pseudomembranous colitis due to high Fx
- 500 mg tid
- 250 or 500 mg capsules |
|
|
Term
|
Definition
- amoxicillin + clavulanate (B-lactamase inhibitor)
- similar to amoxicillin and PenVK, but more nausea and vomiting
- 500mg bid
- variety of capsules, chewables, suspensions |
|
|
Term
|
Definition
- 1st generation cephalosporin
- good 2nd option after PCN
- cross allergy w/ PCN
- good for skin wounds
- prescribed as capsule AND suspension |
|
|
Term
|
Definition
- 1st generation cephalosporin
- longer 1/2 life than Keflex
- cross allergy w/ PCN
- 500mg bid
- 500mg tablets |
|
|
Term
|
Definition
- poor choice for odontogenic infections
- inactivated by stomach acid
- GI disturbance common; cardiotoxicity (macrolide); affects liver metabolism of theophylline, digoxin, tegretol, coumadin, cephalosporin
- 250mg qid |
|
|
Term
|
Definition
- good coverage for odontogenic infection
- associated w/ pseudomembranous colitis
-300mg qid |
|
|
Term
|
Definition
- pelvic infections
- used in combo w/ PCN for head/neck infections
- vomiting when mixed w/ OH
- 500mg qid |
|
|
Term
|
Definition
- BACTERIOSTATIC
- broad spectrum
- hypersensitivity, photosensitivity, GI upset, delayed clotting, discolors teeth, avoid during pregnancy
- 500mg qid |
|
|
Term
|
Definition
- macrolide (like erythromycin)
- very long 1/2 life
- 500mg 1st day, 250mg/day afterwards |
|
|
Term
|
Definition
- macrolide (like erythromycin and zithromax)
- broader spectrum and 1/2 life
- works well for chronic sinusitis
- GI upset, competitive metabolism w/ other drugs
- 500mg bid
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- depression of ventilation
- miosis
- bradycardia
- hypothermia
- indifference and eupohoria, physical dependence |
|
|
Term
|
Definition
|
|
Term
|
Definition
- analgesia
- sedation
- miosis |
|
|
Term
|
Definition
- dysphoria
- tachycardia
- tachypnea
- mydriasis |
|
|
Term
|
Definition
- alter PERCEPTION of pain at spinal cord and CNS
- alter emotional response to pain
- do NOT alter response at afferent nerve ending
- increases GI smooth muscle tone, decreases vasomotor tone
- analgesia, sedation, mood alteration, respiratory and cough suppression |
|
|
Term
Where are opiate receptor agonists metabolized? |
|
Definition
|
|
Term
|
Definition
- naturally occurring opioid
- decreases GI motility (nausea and vomiting)
- true allergy rare
- given w/ 300mg acetaminophen in increasing doses (15mg, 30mg, etc.), or by itself
|
|
|
Term
|
Definition
- hydrocodone
- less GI stress than codeine
- given w/ 500mg acetaminophen in increasing doses (2.5mg, 5mg, etc.) |
|
|
Term
|
Definition
- 5mg given w/ either 325 mg acetaminophen (percocet) or aspirin (percodan) |
|
|
Term
|
Definition
- darvocet
- given w/ acetaminophen
- 50-100mg |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
- very long 1/2 life (25 hrs)
- dolophine
- 5-10 mg |
|
|
Term
|
Definition
- opiate ANTAGONIST
- used to counter effects of opiate agonists
- no effect on normal person
- highest affinity for mu receptor |
|
|
Term
|
Definition
- greater analgesia, fewer side effects in combo w/ narcotic
- antidote to hepatotoxicity = acetylcysteine
- 325-1000 mg |
|
|
Term
|
Definition
- NSAID
- GI irritation and bleeding
- watch out w/ pregnancy
|
|
|
Term
ASA (Acetyl Salicylic Acid) |
|
Definition
- NSAID
- inhibits prostaglandins |
|
|
Term
|
Definition
- selective activity at mu receptor
- inhibits reuptake of serotonin and NE
- may lower seizure threshold |
|
|
Term
|
Definition
- ANTAGONIST at mu receptor
- agonist at kappa and sigma receptors
- about 1/4 as potent as morpine |
|
|
Term
|
Definition
- musculoskeletal pain
- arthritis
- rheumatic fever
- thrombosis
- gout
- Kawasaki syndrome |
|
|